Antimitotic Agents: all 5,052 studies that test it
Page 35 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) PatientsCompletedNCT01262235Phase 1/2
- Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer PatientsCompletedNCT01258192Phase 2
- Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and SolidsCompletedNCT01256268Phase 1
- Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly PatientsCompletedNCT01254513Phase 2
- Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing RegimenCompletedNCT01254279Phase 3
- Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast CancerTerminatedNCT01254136Phase 1/2
- Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerCompletedNCT01253681Phase 1
- Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's LymphomaCompletedNCT01251107Phase 3
- Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV InfectionTerminatedNCT01249443Phase 1
- Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01245959Phase 3
- Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid TumorsWithdrawnNCT01245543Phase 1
- Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial CancerActive, not recruitingNCT01244789Phase 2
- Oral Vinorelbine in Combination With Trastuzumab for Metastatic Breast CancerCompletedNCT01242449Phase 2
- A Study of LCL161 in Combination With Weekly Paclitaxel in Adult Patients With Advanced Solid TumorsCompletedNCT01240655Phase 1
- Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerTerminatedNCT01238133Phase 1
- Sunitinib + Docetaxel as Second-line Treatment in Gastric CancerCompletedNCT01238055Phase 2
- Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast CancerTerminatedNCT01238029Phase 1
- Docetaxel and Oxaliplatin Combination With Locally Advanced or Metastatic Biliary Tract CancerStatus unknownNCT01234051Phase 2
- Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by SurgeryCompletedNCT01229930Phase 2
- Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast CancerWithdrawnNCT01229605Phase 2
- Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALLCompletedNCT01225874Not applicable
- Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of EsophagusCompletedNCT01225523Phase 1
- A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01225302Phase 1
- Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line TherapyStatus unknownNCT01224652Phase 3
- Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent ChemotherapyStatus unknownNCT01224405Phase 3
- To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory CancerCompletedNCT01222780Phase 1
- 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer PatientsStatus unknownNCT01222052Phase 3
- Tesetaxel as First-line Therapy for Metastatic Breast CancerStatus unknownNCT01221870Phase 2
- PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With MyelomaCompletedNCT01220375Phase 2
- Study of Intraperitoneal Carboplatin with IV Paclitaxel and Bevacizumab in Untreated Ovarian CancerCompletedNCT01220154Phase 1
- 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric CancerCompletedNCT01216644Phase 2/3
- Tesetaxel for Previously Treated Patients With Bladder CancerStatus unknownNCT01215877Phase 2
- Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast CancerCompletedNCT01208480Phase 2
- CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)CompletedNCT01206036Phase 1/2
- A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsCompletedNCT01204996Phase 1
- Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the BreastCompletedNCT01204437Phase 2/3
- Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast CancerCompletedNCT01203267Phase 2
- Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian CancerCompletedNCT01196559Phase 2
- Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung CancerCompletedNCT01196234Phase 2
- Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01193595Phase 1
- Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer PatientsStatus unknownNCT01192230Phase 2
- Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-PaclitaxelCompletedNCT01192165Phase 1
- 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid TumorsCompletedNCT01191216Phase 1
- Efficacy and Safety Study of LEP-ETU to Treat Metastatic Breast CancerCompletedNCT01190982Phase 2
- A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01189929Phase 1
- Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate CancerWithdrawnNCT01188408Phase 2
- Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced CancerActive, not recruitingNCT01187199Phase 1
- Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic CancerCompletedNCT01186731Phase 2
- InductionChemo-Radio-Antibody-TreatmentCompletedNCT01181401Phase 2
- Pazopanib and Paclitaxel for Non-Small Cell Lung CancerWithdrawnNCT01179269Phase 2
- A Pilot Study for PK/PD Parameter of Colchicine in Chronic Kidney Disease Patient.CompletedNCT01173107Phase 4
- Primary Chemotherapy in Patients With HER2-positive Early Breast CancerCompletedNCT01172223Phase 1/2
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsCompletedNCT01172028Phase 1
- Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg CapsulesCompletedNCT01170975Phase 1
- Ixabepilone and Pemetrexed/Solid TumorsWithdrawnNCT01170871Phase 1
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)TerminatedNCT01170650Phase 3
- Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer PatientsWithdrawnNCT01169870Phase 2
- A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast CancerWithdrawnNCT01163929Phase 2
- A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer PatientsTerminatedNCT01161368Phase 2
- Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic AdenocarcinomaCompletedNCT01161186Phase 1
- Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric CancerStatus unknownNCT01160419Phase 2
- Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft RecipientsCompletedNCT01160276Phase 1
- A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard TherapyCompletedNCT01159522Phase 1
- A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)WithdrawnNCT01156961Phase 4
- Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate CancerTerminatedNCT01155791Phase 1
- Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNCT01155258Phase 1
- Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT01154920Phase 2
- Liposome Encapsulated Docetaxel (LE-DT) in Patients With Solid TumorsCompletedNCT01151384Phase 1
- Study of Chemo-Immunotherapy in Head and Neck Cancer PatientsStatus unknownNCT01149902Phase 1
- A Combination of Abraxane and Cisplatin in Metastatic Breast CancerCompletedNCT01149798Phase 2
- A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsCompletedNCT01148615Phase 1
- R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCLCompletedNCT01148446Phase 3
- Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentCompletedNCT01140607Phase 1
- Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat LymphomaWithdrawnNCT01139359Phase 1
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian CancerWithdrawnNCT01138137Phase 1
- Paclitaxel and Irinotecan in Advanced Gastric CancerCompletedNCT01136031Phase 1/2
- Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS TumoursCompletedNCT01135563Phase 1
- Radiation Therapy Plus Chemotherapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT01134861Phase 3
- Regimens Comparison for Breast Cancers of Positive Lymph NodesStatus unknownNCT01134523Phase 3
- Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)CompletedNCT01133912Phase 1
- A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR MutationsStatus unknownNCT01131429Phase 2
- Metronomic Therapy in Metastatic Breast Cancer.CompletedNCT01131195Phase 3
- Paclitaxel Plus Bevacizumab for Older Patients With Breast CancerTerminatedNCT01120158Phase 2
- International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic LeukemiaCompletedNCT01117441Phase 3
- Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast CancerTerminatedNCT01113970Phase 1
- Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
- A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1)TerminatedNCT01110603Phase 1
- ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid TumorsCompletedNCT01110486Phase 1
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasCompletedNCT01106872Phase 1
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast CancerCompletedNCT01104259Phase 1
- A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid MalignanciesCompletedNCT01103791Phase 1
- Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid TumorsCompletedNCT01095302Phase 1
- Tesetaxel as Second-line Therapy for Patients With Advanced Gastric CancerStatus unknownNCT01095120Phase 2
- Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDHStatus unknownNCT01092585Phase 2
- Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerTerminatedNCT01090830Phase 1/2
- Study of Neoadjuvant Chemotherapy With Nanoparticle Albumin Bound Paclitaxel, Doxorubicin and Cyclophosphamide (NAC) in Patients With Stages II-III Breast CancerTerminatedNCT01090128Phase 1
- Surgery Alone or With CYC VBL and PRED or CVP Alone in Stage IA or IIA Nodular Lymphocyte-Predominant Hodgkin LymphomaCompletedNCT01088750Phase 4
- Effect of Cabazitaxel on the QTc Interval in Cancer PatientsCompletedNCT01087021Phase 1
- A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDSTerminatedNCT01085656Phase 1
- Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617